Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Watson Talks Up Prochieve And Global Expansion At Analyst Meeting

Executive Summary

Watson Pharmaceutical Inc.'s recent analyst meeting provided a substantial window on a company that is in the midst of a multi-year transformation, with insights into its growth strategy through 2013, but also with some potentially important qualifiers.

You may also be interested in...



Watson Pulls Prochieve From Guidance, But Pushes For Approval

Despite a disappointing advisory committee review for its progesterone gel for preterm birth, Watson said it will continue to push for approval. The company also bolsters its Australian generics business with the acquisition of Ascent.

Chief Executive Change At Teva Illustrates Diversification Emphasis At Major Generic Drug Makers

Most of the top 20 generic drug makers are subsidiaries of diversified pharmas or smaller generics-only plays based in the Far East. But diversification, although long a goal, is now urgent for the three major independent generic firms – Teva, Mylan and Watson.

Can Watson Give Birth To A Pregnancy Franchise As It Helps Lay Lipitor To Rest?

Watson is progressing on a multi-year effort to diversify beyond its core U.S. generics business into branded drugs and international markets.

Related Content

Topics

UsernamePublicRestriction

Register

PS053106

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel